Freezing and zapping: new combo therapy aims to ease bone cancer pain

NCT ID NCT04693377

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding cryoablation (a procedure that freezes and kills cancer cells) to standard radiation therapy provides better pain relief for people whose cancer has spread to their bones. About 40 participants with various cancers will be split into two groups: one receiving radiation alone, the other receiving both cryoablation and radiation. The goal is to see if the combination reduces pain more effectively and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cryoablation (freezing) plus stereotactic body radiation therapy

What this could lead to

If it works, this combination could offer better pain relief for people with cancer that has spread to their bones, potentially reducing the need for strong painkillers.

What could go wrong

This is a small, early-stage trial with only 40 participants. It is not yet proven that adding cryoablation is better than radiation alone, and there may be risks from the procedure itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE IVB PROSTATE CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma colorectal cancer colorectal carcinoma colorectal neoplasm melanoma metastatic carcinoma in the bone metastatic malignant neoplasm metastatic melanoma metastatic prostate carcinoma Neoplasm Metastasis prostate cancer renal cell adenocarcinoma renal cell carcinoma sarcoma thyroid gland carcinoma Thyroid Neoplasms transitional cell carcinoma urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-••••

    Contact